August 3, 2025
General Health

FG Backs National Campaign for Measles-Rubella Vaccine Rollout

The Federal Government of Nigeria has expressed strong support for the national campaign to introduce the Measles-Rubella vaccine into the country’s routine immunization schedule. This move is aimed at boosting child health and preventing preventable diseases among vulnerable populations.

The Minister of Information and National Orientation, Mohammed Idris, reaffirmed the government’s commitment while receiving a delegation from the Centre for Wellbeing and Integrated Nutrition Solutions (C-WINS) led by Dr. Nihinlola Mabogunje in his office in Abuja.

The courtesy visit was part of C-WINS’ advocacy efforts to support the rollout of the combined Measles-Rubella (MR) vaccine across Nigeria. The vaccine introduction campaign is part of a global strategy to eliminate measles and control rubella, both of which continue to threaten the lives of millions of children worldwide.

Minister Idris highlighted the importance of public awareness and orientation in ensuring high acceptance and uptake of the vaccine, noting that the National Orientation Agency (NOA) and media institutions under the ministry would play key roles in sensitizing the public.

“We recognise that effective communication and community engagement are essential to the success of this campaign. The government will leverage all available channels to ensure that Nigerians understand the benefits and safety of the MR vaccine,” he said.

Dr. Mabogunje emphasized that rubella, though less well-known than measles, poses a serious risk to pregnant women and unborn children, often leading to congenital rubella syndrome, which causes birth defects.

Nigeria’s push to introduce the MR vaccine aligns with global health commitments to achieve universal immunization coverage and reduce childhood mortality. The campaign is supported by local and international health partners, including the World Health Organization (WHO) and UNICEF.

The nationwide rollout is expected to commence later this year, targeting children between 9 months and 15 years of age, with mass immunization exercises planned in schools, health centers, and community hubs.